RVPH

Reviva Pharmaceuticals Holdings, Inc. - Common Stock (RVPH)

About Reviva Pharmaceuticals Holdings, Inc. - Common Stock (RVPH)

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Details

Daily high
$0.81
Daily low
$0.78
Price at open
$0.81
52 Week High
$4.28
52 Week Low
$0.48
Market cap
37.1M
Dividend yield
0.00%
Volume
238,486
Avg. volume
636,162
P/E ratio
-1.01

Reviva Pharmaceuticals Holdings, Inc. - Common Stock News

Details

Daily high
$0.81
Daily low
$0.78
Price at open
$0.81
52 Week High
$4.28
52 Week Low
$0.48
Market cap
37.1M
Dividend yield
0.00%
Volume
238,486
Avg. volume
636,162
P/E ratio
-1.01